<i>ABCG2</i> and <i>NCF4</i> polymorphisms are associated with clinical outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP

Duo Liu(Third Affiliated Hospital of Harbin Medical University), Yan Jin(Ministry of Education of the People's Republic of China)
Oncotarget
April 6, 2017
Cited by 13


Related Papers